JASON HARPER: Open Payments
NPI 1568292498 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 74 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $143 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $318 |
| Novo Nordisk Inc | 11 | $155 |
| Otsuka America Pharmaceutical, Inc. | 8 | $148 |
| AstraZeneca Pharmaceuticals LP | 4 | $139 |
| PFIZER INC. | 6 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Phathom Pharmaceuticals, Inc. | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Amgen Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: REXULTI, UBRELVY, Ozempic, QULIPTA, CAPLYTA, FARXIGA, VRAYLAR, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
